Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Mar 29, 2024
04:04
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Neurology Minute